Adrenomyeloneuropathy clinical trials

Explore recruiting adrenomyeloneuropathy clinical trials.

Recruiting adrenomyeloneuropathy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adrenomyeloneuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Randomized, Blinded, Dose-escalation Study to Evaluate the Safety and Efficacy of Intrathecal Administration of AAV9-ABCD1 Gene Therapy (SBT101) in Adult Patients with Adrenomyeloneuropathy

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effect of dimethyl fumarate administered to patients with adrenomyeloneuropathy: a multicenter, placebo controlled, phase IIb/III trial

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Adrenomyeloneuropathy trials by city

Adrenomyeloneuropathy clinical trials

Recruiting adrenomyeloneuropathy studies right now

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

IT and IV Lentiviral Gene Therapy for X-ALD

Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy

Home Exercise for Individuals with Neurodegenerative Disease

Also recruiting in Europe

A Phase 1/2 Randomized, Blinded, Dose-escalation Study to Evaluate the Safety and Efficacy of Intrathecal Administration of AAV9-ABCD1 Gene Therapy (SBT101) in Adult Patients with Adrenomyeloneuropathy

Effect of dimethyl fumarate administered to patients with adrenomyeloneuropathy: a multicenter, placebo controlled, phase IIb/III trial

Adrenomyeloneuropathy trials by city

Other conditions